EX-23.1 16 avte-20240930xex23d1.htm EXHIBIT 23.1

Exhibit 23.1

​

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

​

We hereby consent to the use in this Registration Statement on Form S-4 of Aerovate Therapeutics, Inc. of our report dated December 2, 2024 relating to the financial statements of Jade Biosciences, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

​

/s/ PricewaterhouseCoopers LLP

​

Boston, Massachusetts

December 2, 2024